Page last updated: 2024-11-02

pentoxifylline and Asthenia

pentoxifylline has been researched along with Asthenia in 1 studies

Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.

Research Excerpts

ExcerptRelevanceReference
"The early inclusion of patients with NAFLD and severe asthenic syndrome in the treatment regimen, in addition to the basic therapy of Cytoflavin, achieved a significantly high therapeutic effect in the form of normalization of the main clinical, laboratory and instrumental parameters, as well as a significant reduction in the manifestations of asthenia."1.62[Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome]. ( Eremin, MN; Ivolgin, AF; Karakozov, AG; Katenko, SV; Levchenko, OB; Molodova, AI; Pavlov, AI, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pavlov, AI1
Ivolgin, AF1
Katenko, SV1
Eremin, MN1
Molodova, AI1
Levchenko, OB1
Karakozov, AG1

Other Studies

1 other study available for pentoxifylline and Asthenia

ArticleYear
[Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome].
    Terapevticheskii arkhiv, 2021, Aug-15, Volume: 93, Issue:8

    Topics: Asthenia; Humans; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Saline Solution; Syndrome

2021